Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Appointed director
Quarterly results
Director departure
Inv. presentation
|
|
China Biologic Products Holdings, Inc. (CBPO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/12/2023 |
SC 13D/A
| Parfield International Ltd reports a 0% stake in China Biologic Products Holdings, Inc. |
| 05/02/2023 |
CT ORDER
| Form CT ORDER - Confidential treatment order: |
| 04/30/2021 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 04/22/2021 |
SC 13D/A
| Parfield International Ltd reports a 0% stake in China Biologic Products Holdings, Inc. |
| 04/22/2021 |
SC 13D/A
| HHLR ADVISORS, LTD. reports a 0% stake in China Biologic Products Holdings, Inc. |
| 04/22/2021 |
SC 13D/A
| Centurium Capital Partners 2018, L.P. reports a 0% stake in China Biologic Products Holdings, Inc. |
| 04/22/2021 |
SC 13D/A
| Chow Joseph reports a 0% stake in China Biologic Products Holdings, Inc. |
| 04/22/2021 |
SC 13D/A
| CITIC Capital Holdings Ltd reports a 0% stake in China Biologic Products Holdings, Inc. |
| 04/21/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/21/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/21/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/21/2021 |
SC 13E3/A
| Form SC 13E3/A - Going private transaction by certain issuers: [Amend] |
| 04/20/2021 |
6-K
| Quarterly results |
| 04/20/2021 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 03/29/2021 |
6-K
| Quarterly results |
| 03/01/2021 |
6-K
| Quarterly results |
| 01/25/2021 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 01/25/2021 |
SC 13E3/A
| Form SC 13E3/A - Going private transaction by certain issuers: [Amend] |
| 01/15/2021 |
SC 13D
| CPEChina Fund III, L.P. reports a 9.7% stake in China Biologic Products Holdings, Inc. |
| 01/14/2021 |
SC 13D/A
| Parfield International Ltd reports a 5.5% stake in China Biologic Products Holdings, Inc. |
| 01/14/2021 |
SC 13E3/A
| Form SC 13E3/A - Going private transaction by certain issuers: [Amend] |
| 01/08/2021 |
SC 13D/A
| Chow Joseph reports a 13.8% stake in China Biologic Products Holdings, Inc. |
| 01/08/2021 |
SC 13D/A
| PW Medtech Group Ltd reports a 0% stake in China Biologic Products Holdings, Inc. |
| 01/07/2021 |
6-K
| Quarterly results |
| 01/04/2021 |
SC 13D/A
| Parfield International Ltd reports a 5.5% stake in China Biologic Products Holdings, Inc. |
| 12/31/2020 |
SC 13D/A
| Chow Joseph reports a 3.8% stake in China Biologic Products Holdings, Inc. |
| 12/31/2020 |
SC 13D/A
| Centurium Capital Partners 2018, L.P. reports a 25.6% stake in China Biologic Products Holdings, Inc. |
| 12/31/2020 |
SC 13D/A
| PW Medtech Group Ltd reports a 9.7% stake in China Biologic Products Holdings, Inc. |
| 12/31/2020 |
SC 13D/A
| CITIC Capital Holdings Ltd reports a 12.8% stake in China Biologic Products Holdings, Inc. |
| 12/18/2020 |
SC 13E3/A
| Form SC 13E3/A - Going private transaction by certain issuers: [Amend] |
| 11/25/2020 |
SC 13E3/A
| Form SC 13E3/A - Going private transaction by certain issuers: [Amend] |
| 11/24/2020 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 11/23/2020 |
SC 13D/A
| Temasek Holdings Ltd reports a 3.2% stake in China Biologic Products Holdings, Inc. |
| 11/23/2020 |
SC 13D/A
| HILLHOUSE CAPITAL ADVISORS, LTD. reports a 7.6% stake in China Biologic Products Holdings, Inc. |
|
|
|